Skip to content
Journal ArticleHuman molecular genetics·Graded and published ·Last edited

NR Kept Muscle Power Plants Working in Mice With Rare Myopathy

Graded Preliminary — an experiment in a small number of mice over eight weeks without a dummy treatment group; whether it applies to people is untested.

Animal study. Findings may not carry over to people, which is why the grade is capped at Preliminary.

Design
Animal study
Participants
6
Duration
8 weeks
Funding
Novo Nordisk Foundation, EU Horizon Europe, Prinses Beatrix Spierfonds, ZonMW…
Key Insight

Given early, NR stopped the muscle cell power plants from declining in mice with an inherited muscle disease.


In mice with a rare inherited muscle disease, the power plants of the muscle cells kept working normally when the animals got nicotinamide riboside early in life. The compound, known as NR, is a building block for NAD+. Cells need this molecule to make energy. The disease is called nemaline myopathy type 6 and causes muscle weakness from birth.

The mice carry the same gene change found in most patients. Without treatment, their calf muscles used less oxygen for energy from three months of age, but not at one month. Their NAD+ levels also fell as the disease progressed. So the researchers added NR to the drinking water for eight weeks, starting at four weeks of age. At three months, the treated mice's cell power plants worked about as well as those of healthy mice. Typical tissue changes in the muscle still appeared, though.

There was no dummy treatment group, which the authors name as a weakness. Only a few animals were treated, and how NR works here stayed unclear. Whether it helps people with this disease has not been shown.

Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.